Related Experiment Video
Updated: Sep 17, 2025

Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia
Published on: June 8, 2019
Long-term outcomes of endovascular therapy for chronic limb-threatening ischemia patients with connective tissue
Shohei Ouchi1, Kao Takehisa2, Naotaka Murata3
1Department of Cardiovascular Biology and Medicine, Juntendo University School of Medicine, 2-1-1 Hongo Bunkyo-Ku, Tokyo, 113-8421, Japan.
Insights
Endovascular therapy for chronic limb-threatening ischemia in connective tissue disease patients shows poor outcomes, with high amputation and mortality rates. Further therapeutic advancements are crucial for this patient group.
Area of Science:
- Vascular Surgery
- Connective Tissue Diseases
- Ischemia Research
Background:
- Connective tissue disease (CTD) complicates chronic limb-threatening ischemia (CLTI) management.
- Revascularization in CTD-CLTI patients often yields poor prognosis and high amputation rates.
- Limited data exist on long-term endovascular therapy outcomes for CTD-CLTI.
Purpose of the Study:
- To evaluate the long-term outcomes of endovascular therapy in CLTI patients with CTD.
- To assess major adverse extremity events, amputation-free survival, and all-cause mortality.
- To identify the need for improved therapeutic strategies in this population.
Main Methods:
- Multicenter retrospective cohort study.
- Inclusion of 44 consecutive CLTI patients with CTD.
- Analysis of major adverse extremity events, amputation-free survival, and mortality rates.
Main Results:
- 1-year amputation-free survival: 69.3%; 3-year: 58.3%.
- 1-year survival rate: 85.5%; 3-year: 70.3%.
- High rates of major amputations (18.2%) and death (34.1%) observed.
Conclusions:
- Endovascular therapy for CLTI in CTD patients is associated with significant morbidity and mortality.
- Current outcomes highlight the urgent need for novel therapeutic approaches.
- Further research is essential to improve limb salvage and survival rates.
Abstract:
In patients with connective tissue disease (CTD) and chronic limb-threatening ischemia (CLTI), revascularization is reported to be ineffective, with a poor prognosis and a high rate of lower-limb amputation. However, limited actual data are available. To study the long-term outcomes of endovascular therapy for CLTI patients with CTD, we established a multicenter registry (retrospective cohort study) in Japan. This study looked at major adverse extremity events, amputation-free survival, and all-cause mortality to better understand these rates. We registered 44 consecutive patients. The patients' mean age was 69.6 ± 11.4 years. There were 19 patients (43.2%) with diabetes, but only 4 patients (9.1%) were on dialysis. The average follow-up was 36.1 ± 31.7 months. In 11 patients (25.0%), the target wound healed without requiring lower-limb amputation. Target lesion revascularization occurred in 19 cases (43.2%), while unexpected minor amputations occurred in 11 cases (25.0%), major amputations in 8 cases (18.2%), and death in 15 cases (34.1%). The rates of freedom from major adverse extremity events at 1 and 3 years were 40.3% and 22.3%, respectively. The amputation-free survival rates were 69.3% at 1 year and 58.3% at 3 years. The survival rates were 85.5% at 1 year and 70.3% at 3 years. We conducted a multicenter study to look into the outcomes of CLTI patients with CTD who received endovascular therapy. Given the poor outcomes, more therapeutic advances for CLTI in CTD patients are needed.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease IV: Nursing Management
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

